Enanta Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of ENTA for the last quarter is 18.00 M USD, and it's 4.91% lower compared to the previous quarter. The net income of Q1 24 is -33.41 M USD.